THE SEROPREVALENCE STUDY OF MEASLES, MUMPS, RUBELLA, AND VARICELLA IMMUNITY AMONG THAI ADOLESCENT AND YOUNG ADULT STRATIFIED BY AGE GROUP

Recruiting

• Conditions: MEASLES; ADOLESCENSE; SEROPREVALENCE; VACCINE; seroprevalence of MMR and varicella immunity among adolescence and young adult; MUMPS; VARICELLA; YOUNG ADULTS; RUBELLA; IMMUNITY

• Registration Number: TCTR20220413002
• Lead Sponsor: Mahidol University MTCM. Research funding 2022

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-13
• Study Completion: 2022-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Thai nationality
- Age between 13 - 39 years old at the time of hospital visit
- Visiting hospital for blood testing one or more of any followings; measles, mumps, rubella, or varicella between 2018-2021

Exclusion Criteria

- Immunity checking after MMR or varicella vaccination
- Unable to determine date of birth

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
seropositive rate at the time of hospital visit ELISA method

Secondary Outcome Measures

Name	Time	Method
factors associated with seropositive rate at the time of hospital visit medical record review